African Union drops plans to buy Covid vaccines from Serum, pivots to J&J

The statement comes the day after European and British medicine regulators said they had found possible links between AstraZeneca's vaccine and reports of very rare cases of brain blood clots

The African Union has dropped plans to secure COVID-19 vaccines from the Serum Institute of India for African nations and is exploring options with Johnson & Johnson, the head of the Africa Centres for Disease Control and Prevention said on Thursday.
 

The institute will still supply the AstraZeneca vaccine to Africa through the COVAX vaccine-sharing facility, John Nkengasong told reporters, but the African Union would seek additional supplies from Johnson & Johnson.
 

The statement comes the day after European and British medicine regulators said they had found possible links between AstraZeneca's vaccine and reports of very rare cases of brain